ET
Eben Tessari (CHIEF OPERATING OFFICER) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $501K of KNSA (12,048 sh × $41.56, as filed), executed Dec 15 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$501K
shares × price, as filed
Last traded
Dec 15 2025
Filed Dec 17 2025
Median ADV $60.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $17.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
KNSARecent filings
KNSASALE
Kiniksa Pharmaceuticals International, plc
View filing →
$223K12,323 sh × $18.13
Exec Jan 13 2025
Filed Jan 15 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $470K
23,017 sh × $20.44
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $358K
17,000 sh × $21.04
Exec Nov 18 2024
Filed Nov 20 2024 · 5:30 PM ET